Lapides Asset Management LLC bought a new position in shares of Vitamin Shoppe Inc (NYSE:VSI) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 91,900 shares of the specialty retailer’s stock, valued at approximately $404,000.

Other large investors have also made changes to their positions in the company. Shah Capital Management boosted its position in shares of Vitamin Shoppe by 157.9% during the 4th quarter. Shah Capital Management now owns 3,330,000 shares of the specialty retailer’s stock worth $14,652,000 after acquiring an additional 2,038,667 shares in the last quarter. FMR LLC boosted its position in shares of Vitamin Shoppe by 32.4% during the 2nd quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock worth $14,617,000 after acquiring an additional 307,050 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its position in shares of Vitamin Shoppe by 106.0% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 667,112 shares of the specialty retailer’s stock worth $2,936,000 after acquiring an additional 343,326 shares in the last quarter. Canada Pension Plan Investment Board boosted its position in shares of Vitamin Shoppe by 175.5% during the 3rd quarter. Canada Pension Plan Investment Board now owns 652,600 shares of the specialty retailer’s stock worth $3,491,000 after acquiring an additional 415,700 shares in the last quarter. Finally, GMT Capital Corp acquired a new stake in shares of Vitamin Shoppe during the 3rd quarter worth approximately $3,423,000. Hedge funds and other institutional investors own 99.86% of the company’s stock.

Several analysts recently issued reports on the stock. Barclays reduced their price target on shares of Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. ValuEngine lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Morgan Stanley reduced their price target on shares of Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Finally, Zacks Investment Research upgraded shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research report on Sunday, January 21st. Three research analysts have rated the stock with a sell rating and six have given a hold rating to the company’s stock. Vitamin Shoppe has an average rating of “Hold” and a consensus target price of $5.00.

Shares of Vitamin Shoppe Inc (VSI) opened at $3.85 on Wednesday. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59. The stock has a market cap of $93.51, a P/E ratio of 4.19 and a beta of 0.59. Vitamin Shoppe Inc has a 52-week low of $2.95 and a 52-week high of $23.25.

In related news, major shareholder Vintage Capital Management Llc acquired 133,804 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The stock was acquired at an average price of $4.28 per share, with a total value of $572,681.12. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Shah Capital Management acquired 300,000 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The stock was bought at an average cost of $3.83 per share, with a total value of $1,149,000.00. The disclosure for this purchase can be found here. In the last three months, insiders purchased 1,000,639 shares of company stock valued at $4,387,647. 1.07% of the stock is owned by insiders.

COPYRIGHT VIOLATION WARNING: This article was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://theolympiareport.com/2018/02/14/lapides-asset-management-llc-buys-shares-of-91900-vitamin-shoppe-inc-vsi.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe Inc (NYSE:VSI).

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.